The β2-Adrenoceptor Agonist Terbutaline Specifically Decreases Pulmonary Arterial Pressure By α-Adrenoceptor Antagonism

被引：0
|
作者：
Wenzel, D. [1 ]
Stolle, V. [1 ]
Knies, R. [1 ]
Matthey, M. [1 ]
Welschoff, J. [1 ]
Breuer, J. [1 ]
Fleischmann, B. [1 ]
机构：
[1] Univ Bonn, Bonn, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2270
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Comparative Evaluation of Partial α2-Adrenoceptor Agonist and Pure α2-Adrenoceptor Antagonist on the Behavioural Symptoms of Withdrawal after Chronic Alcohol Administration in Mice
    Arora, Shivani
    Vohora, Divya
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 (02) : 202 - 209
  • [42] Renal effects and adverse effects of β2-adrenoceptor agonist given to children
    Nakamura, Akio
    Niimi, Ryo
    Imaizuki, Akira
    Yanagawa, Yukishige
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 107 - 107
  • [43] The influence of polymorphism at position 16 of the β2-adrenoceptor on the development of tolerance to β-agonist
    Taylor, DR
    Hancox, RJ
    McRae, W
    Cowan, JO
    Flannery, EM
    McLachlan, CR
    Herbison, GP
    JOURNAL OF ASTHMA, 2000, 37 (08) : 691 - 700
  • [44] Actions of β2-Adrenoceptor Agonist Drug on Human Soleus Muscle Contraction
    Crivelli, Giacomo
    Borrani, Fabio
    Capt, Romain
    Gremion, Gerald
    Maffiuletti, Nicola A.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2013, 45 (07): : 1252 - 1260
  • [45] Pharmacological profile of intrathecal fadolmidine, a α2-adrenoceptor agonist, in rodent models
    Tiina Leino
    Timo Viitamaa
    Antti Haapalinna
    Jyrki Lehtimäki
    Raimo Virtanen
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, 380 : 539 - 550
  • [46] Neuroprotection by the α2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia
    Jolkkonen, J
    Puurunen, K
    Koistinaho, J
    Kauppinen, R
    Haapalinna, A
    Nieminen, L
    Sivenius, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 372 (01) : 31 - 36
  • [47] Actions of β2-Adrenoceptor Agonist Drug on Neuromuscular Function after Fatigue
    Crivelli, Giacomo
    Maffiuletti, Nicola A.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2014, 46 (02): : 247 - 256
  • [48] OLODATEROL HYDROCHLORIDE β2-Adrenoceptor Agonist Treatment of COPD Treatment of Asthma
    Cazzola, M.
    Matera, M. G.
    DRUGS OF THE FUTURE, 2013, 38 (04) : 235 - 243
  • [49] Pharmacological profile of intrathecal fadolmidine, a α2-adrenoceptor agonist, in rodent models
    Leino, Tiina
    Viitamaa, Timo
    Haapalinna, Antti
    Lehtimaki, Jyrki
    Virtanen, Raimo
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 380 (06) : 539 - 550
  • [50] The Identification of Indacaterol as an Ultralong-Acting Inhaled β2-Adrenoceptor Agonist
    Baur, Francois
    Beattie, David
    Beer, David
    Bentley, David
    Bradley, Michelle
    Bruce, Ian
    Charlton, Steven J.
    Cuenoud, Bernard
    Ernst, Roland
    Fairhurst, Robin A.
    Faller, Bernard
    Farr, David
    Keller, Thomas
    Fozard, John R.
    Fullerton, Joe
    Garman, Sheila
    Hatto, Julia
    Hayden, Claire
    He, Handan
    Howes, Colin
    Janus, Diana
    Jiang, Zhengjin
    Lewis, Christine
    Loeuillet-Ritzler, Frederique
    Moser, Heinz
    Reilly, John
    Steward, Alan
    Sykes, David
    Tedaldi, Lauren
    Trifilieff, Alexandre
    Tweed, Morris
    Watson, Simon
    Wissler, Elke
    Wyss, Daniel
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (09) : 3675 - 3684
12345